Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes-Reference-Cited by-同舟云学术

Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes

Published:2018-11-09 Issue:2 Volume:98 Page:339-350
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Zeidan Amer M.^ORCID,Giri Smith,DeVeaux Michelle,Ballas Samir K.,Duong Vu H.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-018-3539-7/fulltext.html

Reference58 articles.

1. Garcia-Manero G, Fenaux P (2011) Hypomethylating agents and other novel strategies in myelodysplastic syndromes. J Clin Oncol 29(5):516–523

2. Garcia-Manero G (2015) Myelodysplastic syndromes: 2015 update on diagnosis, risk-stratification and management. Am J Hematol 90(9):831–841

3. Nimer SD (2008) Myelodysplastic syndromes. Blood 111(10):4841–4851

4. Tefferi A, Vardiman JW (2009) Myelodysplastic syndromes. N Engl J Med 361(19):1872–1885

5. Jabbour E, Takahashi K, Wang X, Cornelison AM, Abruzzo L, Kadia T, Borthakur G, Estrov Z, O'Brien S, Mallo M, Wierda W, Pierce S, Wei Y, Sole F, Chen R, Kantarjian H, Garcia-Manero G (2013) Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia. Am J Hematol 88(10):831–837

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic Syndromes and Myelodysplastic Syndromes/Myeloproliferative Neoplasms: A Real-World Experience From a Developing Country;JCO Global Oncology;2024-02

2. How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms;Clinical Hematology International;2022-12-27

3. Myelodysplastic Syndrome: A Real-World Experience from a Developing Country;SSRN Electronic Journal;2022

4. Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis;British Journal of Haematology;2021-12-19

5. From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox;Frontiers in Oncology;2021-10-06